| Mark Alan Edwards, CRNA | |
|
350 Louisiana Ave, Libby, MT 59923-2130 | |
| (406) 293-0100 | |
| Not Available |
| Full Name | Mark Alan Edwards |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 350 Louisiana Ave, Libby, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437266632 | NPI | - | NPPES |
| 93534 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 32552 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark Alan Edwards, CRNA Po Box 1383, Libby, MT 59923-1383 Ph: (406) 291-4032 | Mark Alan Edwards, CRNA 350 Louisiana Ave, Libby, MT 59923-2130 Ph: (406) 293-0100 |
News Archive
News outlets report on a range of health law implementation issues that are causing challenges for consumers, employers and Obamacare advocates.
Lipid Sciences announced today that researchers have successfully used the Company's proprietary "selective delipidation" process to create a modified form of HDL ("good cholesterol") that is known to be more effective in reverse cholesterol transport, the body's natural process for removing lipids from arterial plaque.
Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) that concluded with oral proceedings on May 12, 2009 in Munich, Germany.
Boston University School of Medicine researchers Neil Joseph Ganem, PhD and Anurag Singh, PhD, each have received the Jackie King Young Investigator Awards from the Melanoma Research Alliance (MRA), the largest private funder of melanoma research. Both serve as assistant professors of pharmacology & experimental therapeutics and medicine.
A new study, released as a preprint on the bioRxiv* server, describes the late-stage clinical trial efficacy of a new vaccine candidate based on a deoxyribonucleic acid (DNA) plasmid platform expressing the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Among different constructs of the vaccine plasmid, the RBD was found to produce the most potent and broad immune response.
› Verified 8 days ago
Loren Clausen, RN Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 350 Louisiana Ave, Libby, MT 59923 Phone: 406-293-0100 | |
Debra Lynn Mcraven, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 209 Health Park Dr, Libby, MT 59923 Phone: 406-283-7000 |